Skip to main content

LLS COVID-19 Response Program: Resources for Patients and Caregivers

The Leukemia & Lymphoma Society (LLS) hears from blood cancer patients and caregivers each day about the profound effects of the pandemic on their cancer care and daily lives, including questions about COVID-19 vaccines and how well they work for people with blood cancer.

From the beginning of the pandemic, LLS has been a leader in providing free education and support services to the people we serve, advocating for vaccination policies that consider and serve the unique needs of blood cancer patients. We also conduct our own research studies and support those of others who are providing important data on the safety and efficacy of COVID-19 vaccines for blood cancer patients.

We encourage patients who have specific questions or concerns to speak directly with their doctors and care team. Our Information Specialists – highly trained oncology nurses, social workers and health educators who provide free, personalized assistance to patients, families and healthcare providers – are available to speak one-on-one with patients, caregivers and healthcare providers. Patients and caregivers can call (800) 955-4572 from Monday to Friday, 9 a.m. to 9 p.m. ET or visit

LLS Coronavirus Resources

The Latest Information on COVID-19 FAQ:

Our FAQs are updated frequently to provide the latest information on COVID-19, vaccines and other prevention strategies to help blood cancer patients—and everyone—protect themselves

The LLS National Patient Registry, a project of the Michael J. Garil Patient Data Collective:

A unique opportunity for blood cancer patients to become citizen scientists by joining LLS to increase scientific knowledge about how COVID-19 and COVID-19 vaccines affect them

Study results
New study shows most blood cancer patients benefit from an additional COVID-19 vaccine dose (September 13, 2021)

COVID-19 vaccines provide protection to most blood cancer patients, but one in four have no detectable antibodies (July 22, 2021)

COVID-19 vaccine is safe among blood cancer patients (May 11, 2021)

LLS National Patient Registry begins T-cell study in blood cancer patients (July 15, 2021)

LLS launches the National Patient Registry to answer COVID-19 questions for blood cancer patients (February 17, 2021)

Recent LLS Statements:

LLS Statement on Federal Vaccination Strategy (September 10, 2021)

New COVID-19 staff safety policies at LLS (August 17, 2021)

Statement on FDA Authorization of Third Pfizer and Moderna COVID-19 Vaccine for People with Weakened Immune Systems (August 13, 2021)

Statement on Recent mRNA-based COVID-19 Vaccines Studies for Blood Cancer Patients (April 20, 2021)

The Leukemia & Lymphoma Society Statement on COVID-19 Vaccine Distribution (March 10, 2021)

Patient Support and Education Services:

Free, on-demand webcasts covering topics related to the COVID-19 pandemic.

Listen in to The Bloodline as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients.